| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ZGGS-34 | ZGGS34; ZGGS-34 | Phase 2 Clinical | Suzhou Zelgen Biopharmaceuticals Co Ltd | Solid tumours | Details |
| HDM-2012 | HDM-2012 | Phase 1 Clinical | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | Solid tumours | Details |
| SSS-59 | SSS59; SSS-59 | Phase 1 Clinical | Shenyang Sunshine Pharmaceutical Co Ltd | Neoplasms | Details |